Redcare Pharmacy NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	92.6	92.4	96.9	84.16	66.78	247.41
Short-Term Investments	42.4	111.1	80.7	120	113.32	36.42
Cash & Short-Term Investments	135	203.5	177.6	204.16	180.1	283.83
Cash Growth	-26.96%	14.58%	-13.01%	13.36%	-36.55%	121.30%
Accounts Receivable	156.4	129.5	109.8	103.13	30	27.92
Other Receivables	-	23.3	15	16.17	10.94	8.25
Receivables	156.4	152.8	124.8	119.31	40.95	36.16
Inventory	214.8	214	153.8	135.79	99.71	96.62
Prepaid Expenses	73.1	16.6	18	10.89	6.57	3.7
Other Current Assets	-	32.5	25.8	29.38	16.59	12.45
Total Current Assets	579.3	619.4	500	499.52	343.92	432.76
Property, Plant & Equipment	198.6	190.7	82.6	86.91	85.44	78.26
Long-Term Investments	1.5	1.5	1.4	1.31	1.27	1.47
Goodwill	-	276.2	277.5	277.5	169.57	153.13
Other Intangible Assets	389.9	117.3	133.8	150.61	119.43	104.35
Long-Term Deferred Tax Assets	1.6	1.6	1.4	2.3	0.46	-
Other Long-Term Assets	7.5	7.6	6.6	3.46	9.39	13.11
Total Assets	1,178	1,214	1,003	1,022	729.47	783.08
Accounts Payable	278.7	248	175.3	152	68.94	78.12
Accrued Expenses	-	60.3	55.5	56.79	38.64	36.38
Short-Term Debt	-	-	-	-	-	0.04
Current Portion of Long-Term Debt	23	76.3	1.6	1.63	1.67	1.63
Current Portion of Leases	-	10	8.1	7.15	5.88	4.74
Current Income Taxes Payable	-	0.4	0.5	0.57	0.24	0.78
Other Current Liabilities	73.4	5	8.7	5.6	3.94	2.41
Total Current Liabilities	375.1	400	249.7	223.72	119.31	124.09
Long-Term Debt	331.8	262.9	209.9	204.35	199.75	195.38
Long-Term Leases	-	67.4	27.7	30.68	27.59	26.06
Pension & Post-Retirement Benefits	0.4	0.4	2.4	4.5	5.69	5.95
Long-Term Deferred Tax Liabilities	2.8	4.4	3.6	6.32	7.89	13.55
Other Long-Term Liabilities	-	-	-	-	14.62	2.65
Total Liabilities	710.1	735.1	493.3	469.56	374.84	367.66
Common Stock	755.9	0.4	0.4	0.4	0.36	0.36
Additional Paid-In Capital	-	755.5	754.9	733.03	570.7	566.54
Retained Earnings	-	-358.2	-324.3	-279.26	-285.43	-207.78
Comprehensive Income & Other	-305.7	61.5	53	68.03	69	56.3
Total Common Equity	450.2	459.2	484	522.19	354.63	415.41
Minority Interest	18.1	20	26	29.84	-	-
Shareholders' Equity	468.3	479.2	510	552.03	354.63	415.41
Total Liabilities & Equity	1,178	1,214	1,003	1,022	729.47	783.08
Total Debt	354.8	416.6	247.3	243.79	234.89	227.84
Net Cash (Debt)	-219.8	-213.1	-69.7	-39.63	-54.79	55.99
Net Cash Growth	-	-	-	-	-	-37.80%
Net Cash Per Share	-	-10.60	-3.48	-2.06	-3.05	3.13
Filing Date Shares Outstanding	-	20.11	20.34	20.2	18.2	18.1
Total Common Shares Outstanding	-	20.11	20.34	20.2	18.2	18.1
Working Capital	204.2	219.4	250.3	275.79	224.61	308.68
Book Value Per Share	-	22.83	23.79	25.85	19.49	22.96
Tangible Book Value	60.3	65.7	72.7	94.09	65.63	157.94
Tangible Book Value Per Share	-	3.27	3.57	4.66	3.61	8.73
Land	-	10	6.6	5.3	6.43	37.88
Machinery	-	59.2	53.4	49.74	43.53	35.25
Construction In Progress	-	65.8	1	0.73	3.82	5.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.